DCM
TECH icon

Driehaus Capital Management’s Bio-Techne TECH Stock Holding History

Driehaus Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-109,632
Closed -$9.5M – 404
2022
Q2 		$9.5M Buy
109,632
+2,772
+3% +$260K 0.15% 205
2022
Q1 		$11.6M Sell
106,860
-39,720
-27% -$4.1M 0.14% 204
2021
Q4 		$19M Buy
146,580
+136
+0.1% +$16.7K 0.19% 156
2021
Q3 		$17.7M Buy
146,444
+131,660
+891% +$16M 0.21% 149
2021
Q2 		$1.66M Buy
14,784
+5,608
+61% +$590K 0.02% 318
2021
Q1 		$876K Buy
9,176
+1,928
+27% +$176K 0.01% 362
2020
Q4 		$575K Buy
+7,248
New +$525K 0.01% 356

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Driehaus Capital Management's TECH Position: Q3 2022 in Review

Driehaus Capital Management sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 109,632 shares — an estimated $9.5M sold.

Driehaus Capital Management first reported a position in TECH in Q4 2020 and held it in 7 quarters. The position peaked at $19M in Q4 2021. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Driehaus Capital Management reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 109,632 Bio-Techne shares in Q3 2022, an estimated $9.5M.
  • Driehaus Capital Management first reported a position in Bio-Techne in Q4 2020 and held it in 7 quarters.
  • Driehaus Capital Management's Bio-Techne position peaked at $19M in Q4 2021.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.